Synthorx (Synthorx) Scaled Net Operating Assets : 0.03 (As of Sep. 2019)

View and export this data going back to 2018. Start your Free Trial

What is Synthorx Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Synthorx's operating assets for the quarter that ended in Sep. 2019 was $12.79 Mil. Synthorx's operating liabilities for the quarter that ended in Sep. 2019 was $7.86 Mil. Synthorx's Total Assets for the quarter that ended in Jun. 2019 was $173.39 Mil. Therefore, Synthorx's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2019 was 0.03.

Synthorx Scaled Net Operating Assets Historical Data

The historical data trend for Synthorx's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synthorx Scaled Net Operating Assets Chart

Synthorx Annual Data

Trend

Dec16

Dec17

Dec18

Scaled Net Operating Assets

-2.38

-3.54

-0.89

Synthorx Quarterly Data
	Dec16	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19
Scaled Net Operating Assets	Get a 7-Day Free Trial				-	-0.07	-0.01	0.01	0.03

Competitive Comparison of Synthorx's Scaled Net Operating Assets

For the Biotechnology subindustry, Synthorx's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Synthorx's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Synthorx's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Synthorx's Scaled Net Operating Assets falls into.

Synthorx Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Synthorx's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2018 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2018 )
=	(Operating Assets (A: Dec. 2018 )	-	Operating Liabilities (A: Dec. 2018 ))	/	Total Assets (A: Dec. 2017 )
=	(3.15	-	7.146)	/	4.469
=	-0.89

where

	Operating Assets		(A: Dec. 2018 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	191.506	-	188.356
=	3.15

	Operating Liabilities		(A: Dec. 2018 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	7.146	-	0	-	0
=	7.146

Synthorx's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2019 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Sep. 2019 )
=	(Operating Assets (Q: Sep. 2019 )	-	Operating Liabilities (Q: Sep. 2019 ))	/	Total Assets (Q: Jun. 2019 )
=	(12.785	-	7.855)	/	173.393
=	0.03

where

	Operating Assets		(Q: Sep. 2019 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	163.671	-	150.886
=	12.785

	Operating Liabilities		(Q: Sep. 2019 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	11.708	-	3.351	-	0.502
=	7.855

Synthorx Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Synthorx's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Synthorx (Synthorx) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Synthorx Inc (NAS:THOR) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

11099 North Torrey Pines Road, Suite 290, La Jolla, CA, USA, 92037

Website

http://www.synthorx.com

Executives

Powell Andrew Kenneth William	director	C/O COLLAGENEX PHARMACEUTICALS, INC., 41 UNIVERSITY DRIVE, NEWTOWN PA 18940
Ra Capital Healthcare Fund Lp	10 percent owner	200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116
Ra Capital Management, L.p.	10 percent owner	200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116
Peter Kolchinsky	director, 10 percent owner	200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116
Peter A. Thompson	director, 10 percent owner	C/O ANTHERA PHARMACEUTICALS, INC., 25801 INDUSTRIAL BOULEVARD, SUITE B, HAYWARD CA 94545
Vickie L Capps	director	2985 SCOTT STREET, VISTA CA 92083
Rajeev M. Shah	10 percent owner	200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116
Jay Lichter	director	C/O ARATANA THERAPEUTICS, INC., 11400 TOMAHAWK CREEK PARKWAY, SUITE 340, LEAWOOD KS 66211
Laura Shawver	director, officer: President and CEO	1255 CRESCENT GREEN DRIVE, SUITE 250, CARY NC 27518
Avalon Ventures X, L.p.	10 percent owner	1134 KLINE STREET, LA JOLLA CA 92037
Orbimed Advisors Llc	director, 10 percent owner	601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022
Orbimed Capital Gp Vii Llc	10 percent owner	601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022